Alembic Pharmaceuticals (India) Today
| APLLTD Stock | 1,042 4.00 0.39% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Alembic Pharmaceuticals is trading at 1041.85 as of the 22nd of November 2024, a 0.39 percent increase since the beginning of the trading day. The stock's open price was 1037.85. Alembic Pharmaceuticals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Alembic Pharmaceuticals Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Alembic Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange. The company has 196.56 M outstanding shares. More on Alembic Pharmaceuticals Limited
Moving against Alembic Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Alembic Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alembic Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alembic Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive CEO | Chirayu Amin | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Health Care (View all Sectors) | ||||
Alembic Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Alembic Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAlembic Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alembic Pharmaceuticals' financial leverage. It provides some insight into what part of Alembic Pharmaceuticals' total assets is financed by creditors.
| |||||
Alembic Pharmaceuticals Limited (APLLTD) is traded on National Stock Exchange of India in India and employs 14,858 people. Alembic Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 203.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alembic Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Alembic Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alembic Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 196.56 M outstanding shares.
Alembic Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Alembic Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAlembic Pharmaceuticals holds a total of 196.56 Million outstanding shares. Alembic Pharmaceuticals Limited shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.76 percent of Alembic Pharmaceuticals outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alembic Ownership Details
Alembic Pharmaceuticals Risk Profiles
Although Alembic Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Alembic Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.83 | |||
| Standard Deviation | 2.46 | |||
| Variance | 6.05 | |||
| Risk Adjusted Performance | (0.01) |
Alembic Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alembic Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Alembic Pharmaceuticals Corporate Management
Elected by the shareholders, the Alembic Pharmaceuticals' board of directors comprises two types of representatives: Alembic Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alembic. The board's role is to monitor Alembic Pharmaceuticals' management team and ensure that shareholders' interests are well served. Alembic Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alembic Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charandeep Saluja | Company Officer | Profile | |
| Dr S | Chief Officer | Profile | |
| Udit Amin | Chief Officer | Profile | |
| Chandrahas Shetty | Senior Resources | Profile | |
| Manisha Saraf | Company Officer | Profile |
Other Information on Investing in Alembic Stock
Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.